: Baxter to spin off kidney care unit as part of a flurry of strategic actions


Baxter International Inc. BAX, -7.84% said Friday it plans to embark on a tax-free spin off to shareholders of its Renal Care and Acute Therapies unit into a public company within the next 12-18 months, as part of a strategic realignment of the hospital products specialist. The other major moves include “simplifying’ its operating model and manufacturing footprint and exploring the sale or other actions for its biopharma solutions unit “to further enhance focus and improve capital structure.” Shares of Baxter rose 1% in premarket trades.

This article was originally published by Marketwatch.com. Read the original article here.

Previous article: Minnesota lawmakers launch fresh cannabis legalization effort
Next article: The food trends that will define 2023: fried-chicken burritos, tequila martinis and robots as chefs


Please enter your comment!
Please enter your name here